U.S. market Closed. Opens in 11 hours 34 minutes

LUNG | Pulmonx Corporation Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue68.67M53.66M48.42M32.73M32.59M20.00M
Cost of Revenue18.32M13.80M12.79M11.53M10.18M7.72M
Gross Profit50.35M39.87M35.63M21.20M22.41M12.29M
Operating Expenses112.29M98.50M82.93M53.53M40.25M27.34M
Selling, General & Admin94.21M83.11M69.87M46.07M34.20M20.35M
Research & Development18.08M15.40M13.06M7.46M6.05M6.99M
Other Operating Expenses-673.00K-396.00K-585.00K3.28M-617.00K-916.00K
Operating Income-61.94M-58.64M-47.30M-32.33M-17.84M-15.05M
Other Expenses / Income1.66M67.00K-1.01M314.00K-2.50M-916.00K
Before Tax Income-60.27M-58.57M-48.32M-32.02M-20.34M-18.47M
Income Tax Expenses571.00K353.00K343.00K213.00K363.00K12.00K
Net Income-60.84M-58.92M-48.66M-32.23M-20.70M-18.48M
Interest Expenses3.23M1.07M829.00K3.18M2.32M2.52M
Basic Shares Outstanding37.97M37.10M36.13M35.69M35.43M20.71M
Diluted Shares Outstanding37.97M37.10M36.13M35.69M35.43M20.71M
EBITDA-59.99M-57.50M-47.49M-28.84M-17.66M-15.68M
EBITDA Margin-87.35%-107.16%-98.09%-88.10%-54.17%-78.37%
EBIT-57.04M-57.50M-47.49M-28.84M-18.02M-15.95M
EBIT Margin-83.06%-107.16%-98.09%-88.10%-55.29%-79.72%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙